These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15967285)

  • 1. A competitive low-affinity binding model for determining the mutual and specific sites of two ligands on protein.
    Bai G; Cui Y; Yang Y; Ye C; Liu M
    J Pharm Biomed Anal; 2005 Jul; 38(4):588-93. PubMed ID: 15967285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of competitive binding of ligands to human serum albumin using NMR relaxation measurements.
    Cui YF; Bai GY; Li CG; Ye CH; Liu ML
    J Pharm Biomed Anal; 2004 Feb; 34(2):247-54. PubMed ID: 15013138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
    Simard JR; Zunszain PA; Hamilton JA; Curry S
    J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes.
    Jayalakshmi V; Krishna NR
    J Magn Reson; 2002 Mar; 155(1):106-18. PubMed ID: 11945039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition STD NMR for the detection of high-affinity ligands and NMR-based screening.
    Wang YS; Liu D; Wyss DF
    Magn Reson Chem; 2004 Jun; 42(6):485-9. PubMed ID: 15137040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of protein-ligand binding affinity by NMR: observations from serum albumin model systems.
    Fielding L; Rutherford S; Fletcher D
    Magn Reson Chem; 2005 Jun; 43(6):463-70. PubMed ID: 15816062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining molecular binding sites on human serum albumin by displacement of oleic acid.
    Sarver RW; Gao H; Tian F
    Anal Biochem; 2005 Dec; 347(2):297-302. PubMed ID: 16289007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of competitive binding of ibuprofen and salicylic acid with serum albumin by affinity capillary electrophoresis.
    Li ZM; Wei CW; Zhang Y; Wang DS; Liu YN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1934-8. PubMed ID: 21676661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro binding of leukotriene B4 (LTB4) to human serum albumin: evidence from spectroscopic, molecular modeling, and competitive displacement studies.
    Zsila F; Bikádi Z; Lockwood SF
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3725-31. PubMed ID: 15993588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements.
    Lucas LH; Price KE; Larive CK
    J Am Chem Soc; 2004 Nov; 126(43):14258-66. PubMed ID: 15506793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography.
    Zhu L; Yang F; Chen L; Meehan EJ; Huang M
    J Struct Biol; 2008 Apr; 162(1):40-9. PubMed ID: 18258455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic polymers as biomacromolecular models for studying ligand-protein interactions: a nuclear spin relaxation approach.
    Corbini G; Martini S; Bonechi C; Casolaro M; Corti P; Rossi C
    J Pharm Biomed Anal; 2006 Jan; 40(1):113-21. PubMed ID: 16111852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 19F NMR spectroscopy to screen chemical libraries for ligands that bind to proteins.
    Tengel T; Fex T; Emtenas H; Almqvist F; Sethson I; Kihlberg J
    Org Biomol Chem; 2004 Mar; 2(5):725-31. PubMed ID: 14985813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the binding affinity of chlorogenic acid with two serum albumins.
    Wang Y; Zhang T; Xu J; Du W
    Int J Biol Macromol; 2011 Jan; 48(1):81-6. PubMed ID: 20923680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 19F NMR spectroscopic study on the binding of triflupromazine to bovine and human serum albumins.
    Kitamura K; Kume M; Yamamoto M; Takegami S; Kitade T
    J Pharm Biomed Anal; 2004 Oct; 36(2):411-4. PubMed ID: 15496337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rigorous multiple independent binding site model for determining cell-based equilibrium dissociation constants.
    Drake AW; Klakamp SL
    J Immunol Methods; 2007 Jan; 318(1-2):147-52. PubMed ID: 17141800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin--an optical and NMR spectroscopic investigation.
    Fanali G; Pariani G; Ascenzi P; Fasano M
    FEBS J; 2009 Apr; 276(8):2241-50. PubMed ID: 19298387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saturation transfer difference nuclear magnetic resonance study on the specific binding of ligand to protein.
    Ji Z; Yao Z; Liu M
    Anal Biochem; 2009 Feb; 385(2):380-2. PubMed ID: 19070584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
    Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
    Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.